Adaptimmune Therapeutics PLC (ADAP)
0.6048
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
0.5958
-0.01
(-1.49%)
After-Hours: 20:00
Adaptimmune Therapeutics Shareholders Equity (Quarterly): 79.99M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals PLC | 11.04M |
| NuCana PLC | 5.818M |
| TC BioPharm (Holdings) PLC | 2.535M |
| Verona Pharma PLC | 130.49M |
| Autolus Therapeutics PLC | 476.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 317.44M |
| Total Liabilities (Quarterly) | 237.45M |
| Debt to Equity Ratio | 0.6234 |
| Current Ratio | 3.848 |
| Net Debt Paydown Yield | -4.10% |